We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




CAD Company Selected as Entrepreneurial Company of the Year

By HospiMedica staff writers
Posted on 04 Oct 2007
im3D-Medical Imaging Lab (Torino, Italy), a research center that collaborates closely with medical and clinical specialists worldwide to develop medical imaging systems, has been selected as the Entrepreneurial Company of the Year 2007 by Frost & Sullivan (Palo Alto, CA, USA), a global growth consulting company. More...


The award recognizes im3D's innovative product range, strategic partnerships, and technology competencies, as well as the company's contribution in the European computer-aided detection (CAD) market. Im3D's first commercial product, the CAD-COLON diagnostic system, supports medical specialists in the early diagnosis and prevention of colorectal tumors by increasing diagnostic accuracy and reducing overall reading times.

"The use of CAD in virtual colonoscopy is gaining wide approval as a convenient and very accurate screening tool for colorectal cancer because the CAD algorithms automatically process the raw VC [virtual colonoscopy] images thereby increasing the overall efficiency of the radiologist,” explained Frost & Sullivan research manager Siddharth Saha. "im3D was selected as Frost & Sullivan's 2007 Entrepreneurial Company of the Year based on its advanced medical imaging technology and strong sense of research.”

"im3D-Medical Imaging Lab has with its superlative product offering, strategic partnerships, and technological competence, made its presence felt strongly in the European CAD markets,” emphasized Mr. Saha. "With clear strategies and strong distribution partnerships, the company is poised to carve out a significant market share in the CAD markets for virtual colonoscopy with its CAD-COLON product offering.”

CAD-COLON is one of the first CAD systems to be commercially introduced for virtual colonoscopy, which gives the company a significant competitive advantage. The potential market for the product is vast, given the high incidence of colorectal cancer worldwide and the increased use of virtual colonoscopy as a screening tool to detect polyps very early in their development.

"The software is provided in im3D's custom-built workstation to provide sufficient computing power to harness the full potential of the complex software algorithms of the CAD system,” added Mr. Saha. "This enables im3D-Medical Imaging Lab to sell their CAD-COLON solution independently without the need for partnering with CT [computed tomography] workstation vendors.”


Related Links:
im3D-Medical Imaging Lab
Frost & Sullivan

Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Surgical System
Stealth AXiS
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Emergency Department Campaign Reduces CT Use Without Identified Missed Injuries

Unnecessary head and cervical spine computed tomography (CT) in low-risk trauma patients exposes them to avoidable radiation, prolongs emergency department stays, and increases healthcare costs.... Read more

Surgical Techniques

view channel
Image: Researchers developed a handheld photothermal mid-infrared spectroscopic imaging (MIRSI) system that measures just 8 square inches. Probe light from a visible (red) diode laser and pump light from a modulated quantum cascade laser (QCL) are coupled into optical fibers and delivered to a flexible, handheld imager (blue dashed box). The beams are combined at a short-pass dichroic mirror and focused onto the sample using an off-axis parabolic mirror (OAP). (Image Credit:Rohith Reddy, University of Houston)

Handheld Infrared Imaging Device Supports Tumor Margin Assessment During Surgery

Accurately determining tumor margins during surgery remains challenging. Frozen-section pathology takes time and can miss residual disease, potentially leading to repeat surgery and delayed therapy.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.